Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 599398
                    [Title] => Roche drug helps women with ovarian cancer live longer
                    [Summary] => 
BASEL, Switzerland — Roche announced recently that a second large, phase  III, international study showed that the combination of bevacizumab and  chemotherapy followed by the continued use of bevacizumab alone...
                    [DatePublished] => 2010-08-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

CLINICAL TRIALS UNIT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 599398
                    [Title] => Roche drug helps women with ovarian cancer live longer
                    [Summary] => 
BASEL, Switzerland — Roche announced recently that a second large, phase  III, international study showed that the combination of bevacizumab and  chemotherapy followed by the continued use of bevacizumab alone...
                    [DatePublished] => 2010-08-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Roche drug helps women with ovarian cancer live longer

August 5, 2010 - 12:00am

BASEL, Switzerland — Roche announced recently that a second large, phase III, international study showed that the combination of bevacizumab and chemotherapy followed by the continued use of bevacizumab...

Science and Environment